Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
Nov. 30, 2019
Nov. 30, 2018
CURRENT    
Cash $ 1,081,900 $ 1,182,387
Restricted cash 92,000  
Accounts receivable 438,255 18,914
Inventory, net 959,748 129,121
Prepaid expenses and other current assets 377,305 901,247
Total Current Assets 2,949,208 2,231,669
Patent rights, net 99,002 106,334
Deposit for equipment 196,921 205,664
Property and equipment, net 321,288 113,418
TOTAL ASSETS 3,566,419 2,657,085
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 650,719 380,542
Convertible notes payable 2,758,578 978,361
Accrued interest 266,143 16,767
Derivative liabilities 0 957,301
Total Current Liabilities 3,675,440 2,332,971
Long-term convertible notes payable 1,874,972 167,077
Total Liabilities 5,550,412 2,500,048
Commitments
Capital stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil shares issued and outstanding (2018 - Nil).
Common stock, $0.001 par value 300,000,000 shares authorized, 104,021,836 shares issued and outstanding (2018: 200,000,000 shares authorized, 101,976,899 shares issued and outstanding) 104,022 101,977
Additional paid-in capital 36,480,520 33,341,695
Shares to be issued 20,000  
Treasury stock receivable (3,000,000 shares) (888,000)  
Accumulated deficit (37,662,123) (33,252,338)
Accumulated other comprehensive loss (38,412) (34,297)
Total Stockholders' (Deficit) Equity (1,983,993) 157,037
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $ 3,566,419 $ 2,657,085